fda compounded semaglutide ends shortage, closing the door on Wegovy, Ozempic Novo asks FDA to prevent

As a supplement, researchers found that selenium improved biomarkers of hypothyroidism

There is considerable interest in pairing GLP-1R agonism with glucagon receptor agonism to enhance both energy expenditure to maximize weight loss and potentially leverage the lipid oxidative properties of glucagon in hepatocytes to target nonalcoholic fatty liver disease

Short-term safety profile (up to 68 weeks) shows side effects consistent with other incretin medications plus a new signal for dysesthesia

While stimulation of the microglia cell line SIM-A9 with A1 42 significantly increased TNF- mRNA expression, this effect was suppressed by choline deficiency and Lico E treatment